Activity and safety of SHR3680, a novel antiandrogen, in patients with metastatic castration-resistant prostate cancer: a phase I/II trial
新型抗雄激素药物SHR3680在转移性去势抵抗性前列腺癌患者中的活性和安全性:一项I/II期试验
期刊:BMC Medicine
影响因子:8.3
doi:10.1186/s12916-022-02263-x
Qin, Xiaojian; Ji, Dongmei; Gu, Weijie; Han, Weiqing; Luo, Hong; Du, Chuanjun; Zou, Qing; Sun, Zhongquan; He, Chaohong; Zhu, Shaoxing; Chong, Tie; Yao, Xin; Wan, Ben; Yang, Xinfeng; Bai, Aobing; Jin, Chunlei; Zou, Jianjun; Ye, Dingwei